Turbine valuation, funding and investors
Turbine works in virtual biology platform development, based in Budapest, Hungary. Founded in 2016, it has about 117 employees.
VALUATION · TODAY
$205M +9% after Series B
Range $109M – $350M · Grade BTODAY
+12 MO
$100M
$200M
$300M
$400M
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Seed $3.30M
Series A $20.5M
Series B $25.0M
ValuationBefore first round12-month outlook: where it points, how wide it fansHover the past: the outlook shows what was predicted then
HEADCOUNT · TODAY117 employees
+6%6m growth
+17%1y growth
+24%2y growth
50
100
150
Data from Mar 2024
Predicted in 1 yr $224M +9% vs today
Predicted next raise $29.9M if a round comes
Winding-down probability 19%
- Last round
- Series B · $25.0M · Feb 2026
- Valuation at last round
- $164M · implied
- Headcount
- 117 · up
- Grade
- B
- Founded
- 2016
Turbine valuation today
VCMC values Turbine at $205M today, with a range of $109M to $350M and a grade of B. The valuation starts from its last funding round, a Series B round in Feb 2026.
Valuation by date (134 rows)
Each point is what the model would have shown on that date, using only what was known then; before its first round, a company is valued as a startup because it later raised.
| Date | Valuation | Range | Predicted in 1 yr | Phase | Headcount | Trend | Grade | Winding-down probability |
|---|---|---|---|---|---|---|---|---|
| 1 Jan 2016 | $3.39M | $1.23M – $9.31M | $4.06M (+20%) | before first round | – | unknown | D | 0% |
| 1 Feb 2016 | $3.40M | $1.24M – $9.35M | $4.17M (+23%) | before first round | – | unknown | D | 0% |
| 1 Mar 2016 | $3.41M | $1.24M – $9.38M | $4.28M (+25%) | before first round | – | unknown | D | 0% |
| 1 Apr 2016 | $3.43M | $1.25M – $9.42M | $4.39M (+28%) | before first round | – | unknown | D | 0% |
| 1 May 2016 | $3.44M | $1.25M – $9.45M | $4.51M (+31%) | before first round | – | unknown | D | 0% |
| 1 Jun 2016 | $3.46M | $1.26M – $9.49M | $4.63M (+34%) | before first round | – | unknown | D | 0% |
| 1 Jul 2016 | $3.47M | $1.26M – $9.53M | $4.75M (+37%) | before first round | – | unknown | D | 0% |
| 1 Aug 2016 | $3.56M | $1.30M – $9.78M | $4.88M (+37%) | before first round | – | unknown | D | 0% |
| 1 Sep 2016 | $3.66M | $1.33M – $10.0M | $5.01M (+37%) | before first round | – | unknown | D | 0% |
| 1 Oct 2016 | $3.75M | $1.37M – $10.3M | $5.15M (+37%) | before first round | – | unknown | D | 0% |
| 1 Nov 2016 | $3.86M | $1.40M – $10.6M | $5.29M (+37%) | before first round | – | unknown | D | 0% |
| 1 Dec 2016 | $3.96M | $1.44M – $10.9M | $5.43M (+37%) | before first round | – | unknown | D | 0% |
| 1 Jan 2017 | $4.06M | $1.48M – $11.2M | $5.57M (+37%) | before first round | – | unknown | D | 0% |
| 1 Feb 2017 | $4.17M | $1.52M – $11.5M | $5.72M (+37%) | before first round | – | unknown | D | 0% |
| 1 Mar 2017 | $4.27M | $1.56M – $11.7M | $5.86M (+37%) | before first round | – | unknown | D | 0% |
| 1 Apr 2017 | $4.39M | $1.60M – $12.1M | $6.02M (+37%) | before first round | – | unknown | D | 0% |
| 1 May 2017 | $4.51M | $1.64M – $12.4M | $6.18M (+37%) | before first round | – | unknown | D | 0% |
| 1 Jun 2017 | $4.63M | $1.68M – $12.7M | $6.34M (+37%) | before first round | – | unknown | D | 0% |
| 1 Jul 2017 | $4.75M | $1.73M – $13.0M | $6.51M (+37%) | before first round | – | unknown | D | 0% |
| 1 Aug 2017 | $4.88M | $1.78M – $13.4M | $6.69M (+37%) | before first round | – | unknown | D | 0% |
| 1 Sep 2017 | $5.01M | $1.82M – $13.8M | $6.87M (+37%) | before first round | – | unknown | D | 0% |
| 1 Oct 2017 | $5.14M | $1.87M – $14.1M | $7.05M (+37%) | before first round | – | unknown | D | 0% |
| 1 Nov 2017 | $5.28M | $1.92M – $14.5M | $7.24M (+37%) | before first round | – | unknown | D | 0% |
| 1 Dec 2017 | $5.42M | $1.97M – $14.9M | $7.43M (+37%) | before first round | – | unknown | D | 0% |
| 1 Jan 2018 | $5.57M | $2.03M – $15.3M | $7.63M (+37%) | before first round | – | unknown | D | 0% |
| 1 Feb 2018 | $5.72M | $2.08M – $15.7M | $7.84M (+37%) | before first round | – | unknown | D | 0% |
| 1 Mar 2018 | $5.86M | $2.13M – $16.1M | $8.03M (+37%) | before first round | – | unknown | D | 0% |
| 1 Apr 2018 | $6.02M | $2.19M – $16.5M | $8.25M (+37%) | before first round | – | unknown | D | 0% |
| 1 May 2018 | $6.18M | $2.25M – $17.0M | $8.47M (+37%) | before first round | – | unknown | D | 0% |
| 1 Jun 2018 | $6.34M | $2.31M – $17.4M | $8.70M (+37%) | before first round | – | unknown | D | 0% |
| 1 Jul 2018 | $6.51M | $2.37M – $17.9M | $8.93M (+37%) | before first round | – | unknown | D | 0% |
| 1 Aug 2018 | $6.69M | $2.43M – $18.4M | $9.02M (+35%) | before first round | – | unknown | D | 0% |
| 1 Sep 2018 | $6.87M | $2.50M – $18.9M | $9.10M (+32%) | before first round | – | unknown | D | 0% |
| 1 Oct 2018 | $7.05M | $2.57M – $19.4M | $9.18M (+30%) | before first round | – | unknown | D | 0% |
| 1 Nov 2018 | $7.24M | $2.64M – $19.9M | $9.27M (+28%) | before first round | – | unknown | D | 0% |
| 1 Dec 2018 | $7.43M | $2.71M – $20.4M | $9.35M (+26%) | before first round | – | unknown | D | 0% |
| 1 Jan 2019 | $7.63M | $2.78M – $21.0M | $9.43M (+24%) | before first round | – | unknown | D | 0% |
| 1 Feb 2019 | $7.84M | $2.85M – $21.5M | $9.52M (+21%) | before first round | – | unknown | D | 0% |
| 1 Mar 2019 | $8.03M | $2.92M – $22.1M | $9.60M (+19%) | before first round | – | unknown | D | 0% |
| 1 Apr 2019 | $8.25M | $3.00M – $22.7M | $9.69M (+17%) | before first round | – | unknown | D | 0% |
| 1 May 2019 | $8.47M | $3.08M – $23.3M | $9.77M (+15%) | before first round | – | unknown | D | 0% |
| 1 Jun 2019 | $8.70M | $3.17M – $23.9M | $9.86M (+13%) | before first round | – | unknown | D | 0% |
| 1 Jul 2019 | $8.93M | $3.25M – $24.5M | $9.95M (+11%) | before first round | – | unknown | D | 0% |
| 1 Aug 2019 | $9.02M | $3.28M – $24.8M | $10.0M (+11%) | before first round | – | unknown | D | 0% |
| 1 Sep 2019 | $9.10M | $3.31M – $25.0M | $10.1M (+11%) | before first round | – | unknown | D | 0% |
| 1 Oct 2019 | $9.18M | $3.34M – $25.2M | $10.2M (+11%) | before first round | – | unknown | D | 0% |
| 1 Nov 2019 | $9.27M | $3.37M – $25.5M | $10.3M (+11%) | before first round | – | unknown | D | 0% |
| 14 Nov 2019 | $20.2M | $13.3M – $61.4M | $40.4M (+100%) | after a round | – | unknown | C | 0% |
| 1 Dec 2019 | $20.9M | $13.3M – $61.4M | $40.4M (+93%) | after a round | – | unknown | C | 0% |
| 1 Jan 2020 | $22.2M | $13.3M – $61.4M | $40.4M (+82%) | after a round | – | unknown | C | 0% |
| 1 Feb 2020 | $23.5M | $13.3M – $61.4M | $40.4M (+72%) | after a round | – | unknown | C | 0% |
| 1 Mar 2020 | $24.8M | $13.3M – $61.4M | $40.4M (+63%) | after a round | – | unknown | C | 0% |
| 1 Apr 2020 | $26.3M | $13.3M – $61.4M | $40.4M (+53%) | after a round | – | unknown | C | 0% |
| 1 May 2020 | $27.9M | $13.3M – $61.4M | $40.4M (+45%) | after a round | – | unknown | C | 0% |
| 1 Jun 2020 | $29.6M | $13.3M – $61.4M | $40.4M (+37%) | after a round | – | unknown | C | 0% |
| 1 Jul 2020 | $31.3M | $13.3M – $61.4M | $40.4M (+29%) | after a round | – | unknown | C | 0% |
| 1 Aug 2020 | $33.2M | $13.3M – $61.4M | $40.4M (+22%) | after a round | – | unknown | C | 0% |
| 1 Sep 2020 | $35.2M | $13.3M – $61.4M | $40.4M (+15%) | after a round | – | unknown | C | 0% |
| 1 Oct 2020 | $37.3M | $13.3M – $61.4M | $40.4M (+8%) | after a round | – | unknown | C | 0% |
| 1 Nov 2020 | $39.5M | $13.3M – $61.4M | $40.4M (+2%) | after a round | – | unknown | C | 0% |
| 1 Dec 2020 | $40.4M | $12.9M – $61.4M | $40.4M (0%) | after a round | – | unknown | C | 0% |
| 1 Jan 2021 | $40.4M | $12.2M – $61.4M | $40.4M (0%) | after a round | – | unknown | C | 0% |
| 1 Feb 2021 | $40.4M | $11.6M – $61.4M | $40.4M (0%) | after a round | – | unknown | C | 0% |
| 1 Mar 2021 | $40.4M | $11.1M – $61.4M | $40.4M (0%) | after a round | – | unknown | C | 0% |
| 1 Apr 2021 | $40.4M | $10.5M – $61.4M | $40.4M (0%) | after a round | – | unknown | C | 0% |
| 1 May 2021 | $40.4M | $10.0M – $61.4M | $40.4M (0%) | after a round | – | unknown | C | 0% |
| 1 Jun 2021 | $40.4M | $9.54M – $61.4M | $40.4M (0%) | after a round | – | unknown | C | 0% |
| 1 Jul 2021 | $40.4M | $9.08M – $61.4M | $40.4M (0%) | after a round | – | unknown | C | 0% |
| 1 Aug 2021 | $40.4M | $8.63M – $61.4M | $40.4M (0%) | after a round | – | unknown | C | 0% |
| 1 Sep 2021 | $40.4M | $8.20M – $61.4M | $40.4M (0%) | after a round | – | unknown | D | 0% |
| 1 Oct 2021 | $40.4M | $7.80M – $61.4M | $40.4M (0%) | after a round | – | unknown | D | 0% |
| 1 Nov 2021 | $40.4M | $7.42M – $61.4M | $40.4M (0%) | after a round | – | unknown | D | 0% |
| 1 Dec 2021 | $40.4M | $7.06M – $61.4M | $40.4M (0%) | after a round | – | unknown | D | 0% |
| 1 Jan 2022 | $40.4M | $6.71M – $61.4M | $40.4M (0%) | after a round | – | unknown | D | 0% |
| 1 Feb 2022 | $40.4M | $6.38M – $61.4M | $40.4M (0%) | after a round | – | unknown | D | 0% |
| 1 Mar 2022 | $40.4M | $6.09M – $61.4M | $40.4M (0%) | after a round | – | unknown | D | 0% |
| 1 Apr 2022 | $40.4M | $5.79M – $61.4M | $40.4M (0%) | after a round | – | unknown | D | 0% |
| 1 May 2022 | $40.4M | $5.51M – $61.4M | $40.4M (0%) | after a round | – | unknown | D | 0% |
| 1 Jun 2022 | $40.4M | $5.24M – $61.4M | $40.4M (0%) | after a round | – | unknown | D | 0% |
| 1 Jul 2022 | $40.4M | $4.98M – $61.4M | $40.4M (0%) | after a round | – | unknown | D | 0% |
| 1 Aug 2022 | $40.4M | $4.74M – $61.4M | $40.4M (0%) | after a round | – | unknown | D | 0% |
| 1 Sep 2022 | $40.4M | $4.50M – $61.4M | $40.4M (0%) | after a round | – | unknown | D | 0% |
| 1 Oct 2022 | $40.4M | $4.28M – $61.4M | $40.4M (0%) | after a round | – | unknown | D | 0% |
| 1 Nov 2022 | $40.4M | $4.07M – $61.4M | $40.4M (0%) | after a round | – | unknown | D | 0% |
| 23 Nov 2022 | $105M | $68.7M – $286M | $188M (+80%) | after a round | – | unknown | C | 0% |
| 1 Dec 2022 | $106M | $68.7M – $286M | $188M (+77%) | after a round | – | unknown | C | 0% |
| 1 Jan 2023 | $112M | $68.7M – $286M | $188M (+69%) | after a round | – | unknown | C | 0% |
| 1 Feb 2023 | $117M | $68.7M – $286M | $188M (+61%) | after a round | – | unknown | C | 0% |
| 1 Mar 2023 | $123M | $68.7M – $286M | $188M (+53%) | after a round | – | unknown | C | 0% |
| 1 Apr 2023 | $129M | $68.7M – $286M | $188M (+46%) | after a round | – | unknown | C | 0% |
| 1 May 2023 | $135M | $68.7M – $286M | $188M (+39%) | after a round | – | unknown | C | 0% |
| 1 Jun 2023 | $142M | $68.7M – $286M | $188M (+32%) | after a round | – | unknown | C | 0% |
| 1 Jul 2023 | $149M | $68.7M – $286M | $188M (+26%) | after a round | – | unknown | C | 0% |
| 1 Aug 2023 | $157M | $68.7M – $286M | $188M (+20%) | after a round | – | unknown | C | 0% |
| 1 Sep 2023 | $165M | $68.7M – $286M | $188M (+14%) | after a round | – | unknown | C | 0% |
| 1 Oct 2023 | $173M | $68.7M – $286M | $188M (+9%) | after a round | – | unknown | C | 0% |
| 1 Nov 2023 | $182M | $68.7M – $286M | $188M (+3%) | after a round | – | unknown | C | 0% |
| 1 Dec 2023 | $188M | $67.7M – $286M | $188M (0%) | after a round | – | unknown | C | 0% |
| 1 Jan 2024 | $188M | $64.4M – $286M | $188M (0%) | after a round | – | unknown | C | 0% |
| 1 Feb 2024 | $188M | $61.2M – $286M | $188M (0%) | after a round | – | unknown | C | 0% |
| 1 Mar 2024 | $188M | $58.3M – $286M | $188M (0%) | after a round | 89 | unknown | C | 0% |
| 1 Apr 2024 | $188M | $55.4M – $286M | $188M (0%) | after a round | 89 | unknown | C | 0% |
| 1 May 2024 | $188M | $52.8M – $286M | $188M (0%) | after a round | 89 | unknown | C | 0% |
| 1 Jun 2024 | $188M | $50.1M – $286M | $188M (0%) | after a round | 89 | unknown | C | 0% |
| 1 Jul 2024 | $188M | $47.7M – $286M | $188M (0%) | after a round | 89 | unknown | C | 0% |
| 1 Aug 2024 | $188M | $45.4M – $286M | $188M (0%) | after a round | 94 | flat | C | 0% |
| 1 Sep 2024 | $188M | $43.1M – $286M | $188M (0%) | after a round | 94 | flat | C | 0% |
| 1 Oct 2024 | $188M | $41.0M – $286M | $188M (0%) | after a round | 94 | flat | C | 0% |
| 1 Nov 2024 | $188M | $61.9M – $286M | $188M (0%) | after a round | 110 | up | C | 0% |
| 1 Dec 2024 | $188M | $47.4M – $286M | $188M (0%) | after a round | 110 | up | C | 0% |
| 1 Jan 2025 | $188M | $46.0M – $286M | $188M (0%) | after a round | 110 | up | C | 0% |
| 1 Feb 2025 | $188M | $44.6M – $286M | $187M (-1%) | after a round | 110 | up | C | 0% |
| 1 Mar 2025 | $188M | $43.4M – $286M | $187M (-1%) | after a round | 110 | up | C | 0% |
| 1 Apr 2025 | $188M | $42.1M – $286M | $186M (-1%) | after a round | 110 | up | C | 0% |
| 1 May 2025 | $188M | $40.9M – $286M | $185M (-1%) | after a round | 110 | up | C | 0% |
| 1 Jun 2025 | $188M | $39.6M – $286M | $185M (-2%) | after a round | 110 | up | C | 0% |
| 1 Jul 2025 | $188M | $38.5M – $286M | $184M (-2%) | after a round | 110 | up | D | 0% |
| 1 Aug 2025 | $188M | $37.3M – $286M | $181M (-4%) | after a round | 100 | up | D | 0% |
| 1 Sep 2025 | $188M | $36.2M – $286M | $180M (-5%) | after a round | 100 | up | D | 0% |
| 1 Oct 2025 | $188M | $22.5M – $286M | $174M (-8%) | after a round | 100 | flat | D | 0% |
| 1 Nov 2025 | $188M | $21.4M – $286M | $172M (-8%) | after a round | 100 | flat | D | 0% |
| 1 Dec 2025 | $188M | $27.3M – $286M | $172M (-9%) | after a round | 104 | up | D | 0% |
| 1 Jan 2026 | $186M | $26.1M – $284M | $171M (-9%) | after a round | 104 | up | D | 0% |
| 1 Feb 2026 | $185M | $25.0M – $282M | $169M (-9%) | after a round | 104 | up | D | 0% |
| 25 Feb 2026 | $164M | $108M – $325M | $213M (+30%) | after a round | 104 | flat | B | 35% |
| 1 Mar 2026 | $164M | $108M – $325M | $213M (+30%) | after a round | 104 | flat | B | 35% |
| 1 Apr 2026 | $168M | $108M – $328M | $214M (+27%) | after a round | 110 | flat | B | 32% |
| 1 May 2026 | $173M | $108M – $332M | $215M (+25%) | after a round | 110 | flat | B | 30% |
| 1 Jun 2026 | $177M | $108M – $335M | $217M (+22%) | after a round | 110 | flat | B | 27% |
| 1 Jul 2026 | $182M | $108M – $338M | $218M (+20%) | after a round | 110 | flat | B | 25% |
| 1 Aug 2026 | $188M | $108M – $341M | $219M (+17%) | after a round | 110 | flat | B | 23% |
| 1 Sep 2026 | $193M | $108M – $343M | $220M (+14%) | after a round | 110 | flat | B | 21% |
| 1 Oct 2026 | $201M | $109M – $350M | $224M (+12%) | after a round | 117 | up | B | 19% |
| 24 Oct 2026 | $205M | $109M – $350M | $224M (+9%) | after a round | 117 | up | B | 19% |
Key facts about Turbine
- Founded
- 2016
- Headquarters
- Budapest, Hungary
- Employees
- about 117 +17% in a year
- Total raised
- $49M
- Funding rounds
- 3
- Last round
- Series B Feb 2026
Turbine was founded in 2016 by Daniel Veres, Kristof Szalay and Szabolcs Nagy.
Turbine funding history
Turbine has 3 funding rounds on record, from Nov 2019 to Feb 2026, $49M in total. None disclosed a valuation.
Series B 24 Feb 2026
Led by Interactive Venture Partners; with Beiersdorf Venture Capital, MSD Global Health Innovation, Mercia Ventures, Accel, XTX Ventures, Crane Venture Partners.
Sources: turbine.ai
$25M
Series A 22 Nov 2022
Led by Mercia, MSD Global Health Innovation (GHI) Fund; with Day One Capital, Accel, Delin Ventures, XTX Ventures.
Sources: turbine.ai, techfundingnews.com, cambridgebiocapital.com
$21M
Seed 13 Nov 2019
Led by Delin Ventures; with Atlantic, o2h Ventures.
Sources: biospace.com, finsmes.com
$3.3M
Turbine investors
13 investors have backed Turbine; Delin Ventures, Interactive Venture Partners and Mercia and 1 more led at least one round.
- Mercia lead
- MSD Global Health Innovation (GHI) Fund lead
- Accel 2 rounds
- XTX Ventures 2 rounds
- Beiersdorf Venture Capital
- Day One Capital
- Mercia Ventures
- MSD Global Health Innovation
What Turbine does
Turbine works in tech companies, with 14 recorded offerings and customers in biotechnology and pharmaceuticals.
Turbine Ltd. is a Hungarian company engaged in the development of AI-based solutions for virtualizing biological experiments and accelerating drug discovery. The company provides platforms and tools for target discovery, de-risking, and clinical translatability, as well as a virtual lab that simulates experimental data and supports in silico predictions, wet lab validation, and interpretation. Turbine serves biopharma companies globally, supporting research and development in drug discovery and clinical decision-making.
Description from Veridion's company data.
Products and services
- Virtual Biology Platform Development
- AI-Driven Drug Discovery Solutions
- Virtual Disease Model Simulation
- Target Discovery and De-Risking Services
- In Silico Drug Response Prediction
- Wet Lab Validation Services
- Clinical Translatability Enhancement Solutions
- Mechanistic Biological Insight Generation
- Workflow Integration Solutions
- Self-Serve Virtual Experimentation Services
- Predictive Simulation Tool Development
- Clinical Decision Support Solutions
- Biotechnology Data Analytics Services
- Clinical Trial Design Optimization
Markets
- Biotechnology
- Pharmaceuticals
Technology
- AI-Driven Virtual Biology
- In Silico Predictions
- Wet Lab-In-The-Loop Validation
- Simulation of Biological Experiments
Business model
- Business-to-Business
- Software-as-a-Service
- Enterprise
Industry codes (NAICS)
- 513210 Software Publishers 70% match
- 541714 Research and Development in Biotechnology (except Nanobiotechnology) 30% match
Questions about Turbine
What is Turbine worth?
Valuation $205M (range $109M to $350M), as of 24 Oct 2026.
Has Turbine raised money?
Turbine has 3 funding rounds on record, from Nov 2019 to Feb 2026, $49M in total. None disclosed a valuation.
Who has invested in Turbine?
Delin Ventures, Interactive Venture Partners, Mercia, MSD Global Health Innovation (GHI) Fund, Accel and XTX Ventures, and 7 more. Lead investors include Delin Ventures, Interactive Venture Partners, Mercia and MSD Global Health Innovation (GHI) Fund.
How many people work at Turbine?
About 117, up 17% over the last year. Headcount grew from 89 in Mar 2024 to 117 in Sep 2026.
What does Turbine do?
Turbine works in tech companies, with 14 recorded offerings and customers in biotechnology and pharmaceuticals. Its main offerings are virtual biology platform development, AI-Driven drug discovery solutions and virtual disease model simulation.
When was Turbine founded, and where is it based?
Turbine was founded in 2016 and is based in Budapest, Hungary. It has about 117 employees, up 17% over the last year.